Wikidata

(Q61894510)

English

Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as add-on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes

clinical trial

In more languages

Statements

short name
SUSTAIN™ 4 (English)
0 references
title
Efficacy and Safety of Semaglutide Once Weekly Versus Insulin Glargine Once Daily as Add on to Metformin With or Without Sulphonylurea in Insulin-naïve Subjects With Type 2 Diabetes (English)
0 references
country
Argentina
0 references
Croatia
0 references
France
0 references
Germany
0 references
India
0 references
Mexico
0 references
Netherlands
0 references
Romania
0 references
Slovakia
0 references
Slovenia
0 references
South Africa
0 references
United Kingdom
0 references
start time
4 August 2014
0 references
end time
3 September 2015
0 references
number of participants
1,089
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61894510&oldid=2109076500"